Oncology & Cancer
Novel compound restores immune response in patients with melanoma
A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017.
Dec 8, 2017
0
5
Annals of Oncology
Oncology & Cancer
First line combination therapy improves progression-free survival in advanced lung cancer
A new combination therapy for the first line treatment of advanced non-squamous non-small-cell lung cancer (NSCLC) improves progression-free survival (PFS), according to results of the phase III IMpower150 trial presented ...
Dec 7, 2017
0
1
Oncology & Cancer
Blood test could help predict skin cancer's return
Cancer Research UK scientists have discovered that testing skin cancer patients' blood for tumour DNA could help predict the chances of an aggressive cancer returning.
Dec 5, 2017
0
2
Oncology & Cancer
Nivolumab may induce successful depletion of HIV reservoir
(HealthDay)—Nivolumab treatment for non-small-cell lung cancer may induce successful depletion of HIV reservoir, according to a letter to the editor published online Dec. 1 in the Annals of Oncology.
Dec 4, 2017
0
18
Oncology & Cancer
Cancer drug leads to 'drastic decrease' in HIV infection in lung cancer patient
Doctors in France have found the first evidence that a cancer drug may be able to eradicate HIV-infected cells in humans.
Nov 30, 2017
0
7
Oncology & Cancer
Researchers find genetic pathways to individualized treatment for advanced prostate cancer
Researchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced prostate cancer. This discovery can guide health care providers ...
Nov 1, 2017
0
4
Oncology & Cancer
Queen's University Belfast leads study to transform prostate cancer treatment
Queen's University Belfast has led the world's largest research study using a diagnostic test developed by Almac Diagnostics, to better understand the biology of prostate cancer tumours, which could lead to a transformation ...
Oct 23, 2017
1
2
Diseases, Conditions, Syndromes
Oncogenic oral HPV DNA detected in 3.5 percent of adults
(HealthDay)—Men have a higher prevalence of oncogenic oral human papillomavirus (HPV) than women, and prevalence increases with the number of lifetime oral sexual partners and tobacco use, according to a study published ...
Oct 20, 2017
0
0
Oncology & Cancer
Risk for developing HPV-related throat cancer low
The prevalence of throat (oropharyngeal) cancers caused by the human papilloma virus (HPV) has increased in recent decades, and some groups are much more likely than others to have the oral HPV infections that can cause these ...
Oct 19, 2017
0
1
Oncology & Cancer
Does stronger initial response to cancer treatment predict longer overall survival?
It seems like such a simple question: Do patients whose tumors shrink more in response to targeted treatment go on to have better outcomes than patients whose tumors shrink less? Actually, the answer seems simple too. In ...
Aug 15, 2017
0
18
